New patients treated for PNE with desmopressin should only be prescribed an oral formulation.
PNE新患者仅限用去氨加压素的口服剂型。
2
Objective To study the adverse drug reaction (ADR) of desmopressin (DDAVP) in clinical application, improving clinical medication.
目的了解和分析去氨加压素在临床应用中不良反应，促进临床合理用药。
3
Prebiopsy desmopressin administration decreases the risk of bleeding and hematoma size in patients undergoing percutaneous kidney biopsy without a cost increase.